modafinil has been researched along with Menopause in 2 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aims to obtain preliminary data on the efficacy of armodafinil for improving menopause-related fatigue and quality of life." | 9.22 | Armodafinil for fatigue associated with menopause: an open-label trial. ( Barsky, M; Cohen, L; Freeman, MP; Galvan, T; Joffe, H; Kim, S; Meyer, F; Petrillo, L, 2016) |
| " In this work, we developed a mouse model of menopause by bilateral ovariectomies (OVXs) and investigated whether menopausal mental symptoms can be ameliorated by psychostimulant modafinil (MOD) as well as explored the underlying mechanisms." | 8.02 | Chronic modafinil therapy ameliorates depressive-like behavior, spatial memory and hippocampal plasticity impairments, and sleep-wake changes in a surgical mouse model of menopause. ( Behnisch, T; Chen, YQ; Hu, ZZ; Huang, ZL; Wang, CY; Yan, YD; Yang, SR; Ye, CB, 2021) |
| "This study aims to obtain preliminary data on the efficacy of armodafinil for improving menopause-related fatigue and quality of life." | 5.22 | Armodafinil for fatigue associated with menopause: an open-label trial. ( Barsky, M; Cohen, L; Freeman, MP; Galvan, T; Joffe, H; Kim, S; Meyer, F; Petrillo, L, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yan, YD | 1 |
| Chen, YQ | 1 |
| Wang, CY | 1 |
| Ye, CB | 1 |
| Hu, ZZ | 1 |
| Behnisch, T | 1 |
| Huang, ZL | 1 |
| Yang, SR | 1 |
| Meyer, F | 1 |
| Freeman, MP | 1 |
| Petrillo, L | 1 |
| Barsky, M | 1 |
| Galvan, T | 1 |
| Kim, S | 1 |
| Cohen, L | 1 |
| Joffe, H | 1 |
1 trial available for modafinil and Menopause
| Article | Year |
|---|---|
Armodafinil for fatigue associated with menopause: an open-label trial.
Topics: Adult; Aged; Benzhydryl Compounds; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; | 2016 |
1 other study available for modafinil and Menopause
| Article | Year |
|---|---|
Chronic modafinil therapy ameliorates depressive-like behavior, spatial memory and hippocampal plasticity impairments, and sleep-wake changes in a surgical mouse model of menopause.
Topics: Animals; Female; Hippocampus; Menopause; Mice; Modafinil; Neuronal Plasticity; Sleep, REM; Spatial B | 2021 |